Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

CSL Limited

CSL

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 32,065 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

Vanguard US Total Market Shares Index ETF

VTS

VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.

Aldoro Resources Limited

ARN

Aldoro Resources Ltd. engaged in the exploration and development of minerals. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2018-09-13. The firm has a portfolio of critical mineral projects, including rare earth, niobium, lithium, rubidium and base metal projects. Its project is the Kameelburg REE/Niobium Carbonatite Project in Namibia. Its other projects are based in Western Australia, including the Wyemandoo lithium-rubidium project, the Niobe lithium-rubidium-tantalum Project and the Narndee Igneous Complex in Western Australia. The Wyemandoo critical metal pegmatite project comprises four exploration licenses (E57/1017, E58/571, E58/555 and E59/2431) that overlie part of the Windimurra Igneous Complex. The Niobe Rb-Li Project consists of 195-ha mining lease application over part of the Dalgaranga-Mount Farmer pegmatite swarm located approximately 70-kilometer northwest of Mount Magnet. The Narndee Project covers a large portion of the ultramafic zone of the Narndee Igneous Complex.

AGL Energy Limited.

AGL

AGL Energy Ltd. is a renewable energy company, which engages in the provision of natural gas distribution services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2006-10-12. The firm also owns an electric vehicle (EV) software platform. The firm's segments include Customer Markets, Integrated Energy and Investments. The Customer Markets segment comprises the consumer and large business customer portfolios responsible for the retailing of electricity, gas, broadband/mobile/voice, solar and energy efficiency products and services to residential, small and large business customers. The Integrated Energy segment operates its power generation portfolio and other key assets, including coal, gas, wind and hydro generation facilities, grid-scale batteries, natural gas storage and production facilities, and development projects. The Investments segment comprises its interests in the ActewAGL Retail Partnership, Tilt Renewables, Ovo Energy Australia and other investments.